Rate My Professor Beata Bajorek

Professor Bajorek's research focuses on quality use of medicines, optimising pharmacotherapy, medication safety and risk assessment in high-risk patients, advanced pharmacy practice including full-scope practice, pharmacy-led interventions, clinical pharmacology and therapeutics, cardiovascular and stroke care, and clinical intervention studies. Fields of research include clinical pharmacology and therapeutics (30%), cardiovascular medicine and haematology nec (40%), and clinical pharmacy and pharmacy practice (30%). She has supervised over 25 higher degree research candidates, mentored health practitioners and researchers, served over 15 years on Human Research Ethics Committees including as Chair, developed and delivered courses in pharmacotherapy, clinical practice and research methods, and contributed to Heart Foundation and National Stroke Foundation clinical guidelines. Key publications include 'Overcoming barriers to adherence through innovative injectable medications: A systematic review of therapeutic options for cardiovascular disease, reported adherence, and perspectives on their use' (2026, British Journal of Clinical Pharmacology); 'Ensuring the quality use of medicines in clinical trials: A review and perspective on optimising the role of pharmacists' (2026, Research in Social and Administrative Pharmacy); 'Exploring the potential economic benefit of modafinil for post-stroke fatigue: A cost-effectiveness evaluation in the Australian context' (2021, International Journal of Stroke); and 'Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention' (2005, Journal of the American Geriatrics Society). She is an investigator on the grant 'Reducing debilitating fatigue after stroke to improve Quality of Life' (2020–2026, $1,055,675, Department of Health and Aged Care).